VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis

NACompletedINTERVENTIONAL

Enrollment

620

Participants

Timeline

Start Date

January 31, 1996

Study Completion Date

January 31, 2003

Conditions

Deep-Vein ThrombosisPulmonary Embolism

Interventions

DRUG

5 mg folic acid, 50 mg pyridoxine and 0.4 mg cyanocobalamin

Trial Locations (1)

Leyenburg Hospital (currently HAGA-hospital), The Hague

All Listed Sponsors

collaborator

Netherlands Heart Foundation

OTHER

lead

Radboud University Medical Center

OTHER

NCT00314990 - VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis | Biotech Hunter | Biotech Hunter